Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment

BACKGROUND/AIMS: Disease-modifying therapy for Alzheimer's disease (AD) has led to a need for biomarkers to identify prodromal AD and very early stage of AD dementia. We aimed to identify the cutoff values of cerebrospinal fluid (CSF) biomarkers for detecting prodromal AD. METHODS: We assessed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dement Geriatr Cogn Dis Extra
Main Authors: Park, Jung Eun, Choi, Kyu Yeong, Kim, Byeong C., Choi, Seong-Min, Song, Min-Kyung, Lee, Jang Jae, Kim, Jahae, Song, Ho-Chun, Kim, Hoo-Won, Ha, Jung-Min, Seo, Eun Hyun, Song, Woo Keun, Park, Sung-Gyoo, Lee, Jung Sup, Lee, Kun Ho
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2019
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6465729/
https://ncbi.nlm.nih.gov/pubmed/31011328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000496920
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados